[August 28, 2015] |
|
Wolters Kluwer Clinical Drug Solutions Trusted by 25 of the 27 2015-2016 Honor Roll Hospitals Ranked by U.S. News & World Report
The Health division of Wolters
Kluwer, a leading global provider of information and point of
care solutions for the healthcare industry, announced today that its Clinical
Drug Information solutions are used in 25 out of the 27
top-scoring hospitals achieving Honor Roll status in U.S. News &
World Report Best Hospitals and Best Children's Hospitals 2015-2016
rankings. Additionally, its Lexicomp® drug
references are used by 19 of the 20 top-ranked pediatric hospitals for
neonatology from the U.S. News & World Report 2015-2016 Best
Children's Hospitals list.
The 2015-16 hospital rankings evaluated surveys of more than 140,000
physicians across nearly 5,000 medical centers in the U.S. High scores
within at least six of the 16 specialties evaluated earned 15 hospitals
a place on the Honor Roll. Death rates, patient safety and hospital
reputation were a few of the many factors considered. In the category of
best children's hospitals, evaluations were conducted across 10
specialties, and high scores in three or more of the 10 specialties
examined earned Honor Roll status for 12 hospitals.
Wolters Kluwer's Clinical Drug Information unites the expertise of more
than 300 professionals to provide aligned drug information resources
across its leading applications, Lexicomp, Medi-Span® and
Facts & Comparisons®. Thousands of hospitals in the U.S.
use clear, concise Lexicomp and Facts & Comparisons drug
refeences online, on mobile apps, and integrated into EMR functions
to provide clinically relevant drug content and interactive clinical
tools at the point of care. Hospitals trust Medi-Span drug
data, integrated in their EMRs, to power medication safety
screenings and meaningful clinical alerts. Together, these aligned
solutions help health systems reduce medication errors, enhance patient
safety, lower system-wide costs, and increase workflow efficiency
throughout the continuum of care.
"Once again, Wolters Kluwer is proud to be the trusted drug information
provider to so many of the nation's top hospitals, according to the
prestigious U.S. News & World Report rankings," said Denise
Basow, MD, President & CEO of Clinical Effectiveness at Wolters Kluwer.
"The strong, ongoing relationships between Clinical Drug Information and
these respected, high-performing healthcare institutions serve as a
testament to our commitment to quality and innovation and to the
hospitals' dedication to superior patient care."
About Wolters Kluwer
Wolters Kluwer is a global leader in professional information services.
Professionals in the areas of legal, business, tax, accounting, finance,
audit, risk, compliance and healthcare rely on Wolters Kluwer's market
leading information-enabled tools and software solutions to manage their
business efficiently, deliver results to their clients, and succeed in
an ever more dynamic world.
Wolters Kluwer reported 2014 annual revenues of €3.7 billion. The group
serves customers in over 170 countries, and employs over 19,000 people
worldwide. The company is headquartered in Alphen aan den Rijn, the
Netherlands. Wolters Kluwer shares are listed on Euronext Amsterdam
(WKL) and are included in the AEX and Euronext 100 indices. Wolters
Kluwer has a sponsored Level 1 American Depositary Receipt program. The
ADRs are traded on the over-the-counter market in the U.S. (WTKWY).
Wolters Kluwer Health is a leading global provider of information and
point of care solutions for the healthcare industry. For more
information about our products and organization, visit www.wolterskluwerhealth.com,
follow @WKHealth
or @Wolters_Kluwer
on Twitter (News - Alert), like us on Facebook,
follow us on LinkedIn,
or follow WoltersKluwerComms on YouTube.
View source version on businesswire.com: http://www.businesswire.com/news/home/20150828005446/en/
[ Back To Mobile World Congress's Homepage ]
|